Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis.

Asian Pac J Cancer Prev · 2021 · PMC8850882 · PMID 34582654

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

There were a gradual and highly significant decrease (p less than 0.01) the cancerous cell viability using SRB in both MCF-7 and MDA-MB-231 cancerous cells upon TQ+TRAIL treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.